Skip to content
A9075Assembly2023-2024 SessionSame asS927

Require Insurer Cancer Gene Tests

Official title

“Requires health insurance policies to cover comprehensive genetic screening for ovarian and prostate cancers”

Sponsor Amanda SeptimoAD-84Affects Finance
Status
In Assembly Committee
Insurance
Impact
8/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Insurance

What's happening

This bill requires New York health insurance policies to fully cover genetic and FDA-approved biomarker testing for ovarian and prostate cancers, including for family members, with no deductibles or coinsurance.

Why it matters

  1. Enables early detection and prevention. By requiring full coverage of genetic and biomarker testing for both patients and their family members, the bill could help identify individuals at higher risk for ovarian and prostate cancers sooner, potentially leading to earlier intervention and improved health outcomes.

  2. Removes financial barriers to advanced diagnostics. The mandate that insurers cover all costs without deductibles or coinsurance ensures that cost does not prevent patients or family members from accessing potentially life-saving genetic tests, making advanced cancer screening more equitable.

  3. Protects against genetic discrimination. The bill explicitly prohibits insurance companies from using genetic test results against family members for coverage purposes, addressing concerns about genetic discrimination that might otherwise discourage people from getting tested.

  4. Expands the role of genetic counseling in treatment planning. By including board-certified geneticists and counselors in the coverage criteria, the legislation recognizes the importance of expert guidance in interpreting genetic risks and tailoring cancer prevention or treatment strategies.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Require Insurer Cancer Gene Tests

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Amanda Septimo

Assembly Member · Assembly District 84

No co-sponsors yet.

History

  1. Referred to insurance

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S927Senate

Cover Genetic Cancer Screening

In Senate Committee · Insurance · Sponsor Roxanne J. Persaud

Impact 8 · Significant0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

9075

IN ASSEMBLY

February 6, 2024

Introduced by M. of A. SEPTIMO -- read once and referred to the Committee on Insurance

AN ACT to amend the insurance law, in relation to requiring health insurance policies to fully cover comprehensive genetic testing and FDA approved biomarker testing for ovarian and prostate cancers

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. This act shall be known and may be cited as the "Ana Lucia act".

§ 2. Paragraph 11-a of subsection (i) of section 3216 of the insurance law is amended by adding a new subparagraph (C) to read as follows:

(C) (i) Such policy shall provide additional full coverage for comprehensive genetic testing and FDA approved testing based on family or person's history for prostatic and ovarian cancer when recommended by a doctor, a board-certified geneticist or a board-certified genetic counselor. Such coverage shall also be provided after the patient's initial diagnosis. Patients need to know if they carry the genetic or inheritance mutation, which can help to determine possible treatments. Genetic screening shall be covered for prostate and ovarian cancer patients' family members. The genetic result shall not be used against family members that carry the genetic or inheritance mutation for insurance coverage purposes.

(ii) All costs associated with such additional full coverage shall not be subject to annual deductibles and coinsurance but shall be borne solely by the insurer.

§ 3. Paragraph 11-a of subsection (l) of section 3221 of the insurance law is amended by adding a new subparagraph (C) to read as follows:

(C)(i) Such policy shall provide additional full coverage for comprehensive genetic testing and FDA approved testing based on family or person's history for prostatic and ovarian cancer when recommended by a doctor, a board-certified geneticist or a board-certified genetic counselor. Such coverage shall also be provided after the patient's initial diagnosis. Patients need to know if they carry the genetic or inheritance mutation, which can help to determine possible treatments. Genetic

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD00460-01-3

screening shall be covered for prostate and ovarian cancer patients' family members. The genetic result shall not be used against family members that carry the genetic or inheritance mutation for insurance coverage purposes.

(ii) All costs associated with such additional full coverage shall not be subject to annual deductibles and coinsurance but shall be borne solely by the insurer.

§ 4. Subsection (z-1) of section 4303 of the insurance law is amended by adding a new paragraph 3 to read as follows:

(3)(A) Such policy shall provide additional full coverage for comprehensive genetic testing and FDA approved testing based on family or person's history for prostatic and ovarian cancer when recommended by a doctor, a board-certified geneticist or a board-certified genetic counselor.

(B) All costs associated with such additional full coverage shall not be subject to annual deductibles and coinsurance but shall be borne solely by the insurer. Such coverage shall also be provided after the patient's initial diagnosis. Patients need to know if they carry the genetic or inheritance mutation, which can help to determine possible treatments. Genetic screening shall be covered for prostate and ovarian cancer patients' family members. The genetic result shall not be used against family members that carry the genetic or inheritance mutation for insurance coverage purposes.

§ 5. This act shall take effect on the sixtieth day after it shall have become a law and shall apply to all policies, contracts and certificates issued, renewed, modified, altered or amended on or after such date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.